FDA cleared the SPINEsim v1.0 from Mdsim S.A. on Sep 15, 2026 under K261861, a traditional 510(k). The device falls under product code LLZ, System, Image Processing, Radiological, regulated at 21 CFR 892.2050 as a Class 2 device. The review panel was Radiology.

FDA logged the submission as received on Jun 4, 2026. The decision came 103 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.

This is the only decision on file for Mdsim S.A. in the last 12 months of the tracker.